Department of Health, University of Girona, Girona Cancer Registry-Catalan Cancer Plan, Girona, Italy.
Eur J Cancer Prev. 2010 Jul;19(4):247-55. doi: 10.1097/CEJ.0b013e328339e2f3.
The aim of this study was to estimate the incidence of leukaemias and lymphomas in children according to the International Classification of Childhood Cancer third edition (ICCC-3) in the population covered by the Girona, Valencia, and Zaragoza population-based cancer registries and compare it with the incidence rates in other European countries. All haematological malignancies (HMs) registered between 1993 and 2002 in children below 15 years of age were included in the study. Pathological and haematological diagnoses were reviewed, recoded according to International Classification of Diseases for Oncology-3 and reclassified on the basis of ICCC-3. Sex and age-adjusted incidence rates were calculated, using the world population as standard. Five hundred and seventy-one HMs were registered in the Girona, Valencia and Zaragoza Cancer Registries during the study period. According to ICCC-3, precursor cell leukaemias were the most frequent HMs in children and constituted 60% of all HMs (an age-adjusted incidence rate of 42.7 per million children-years). The second most frequent childhood HM was Hodgkin lymphoma (11.2% of all HMs), yielding an age-adjusted standardized incidence rate of 6.3 per million children-years. With regard to myeloid lineage, acute myeloid leukaemias were the most frequent with a rate of 7.9 per million children-years. The standardized incidence rates for lymphoid leukaemia (1.19) and Burkitt lymphoma (3.94) were statistically higher than the rates observed in Europe. Compared with European data, Spain has a high incidence of lymphoid leukaemias and lymphomas. In particular, a high incidence of Burkitt lymphoma was observed. The causes of this geographical variation are still unknown.
本研究旨在根据国际儿童癌症分类第 3 版(ICCC-3),估算在赫罗纳、瓦伦西亚和萨拉戈萨人群癌症登记处覆盖的人群中儿童白血病和淋巴瘤的发病率,并与其他欧洲国家的发病率进行比较。本研究纳入了 1993 年至 2002 年期间年龄在 15 岁以下的所有儿童血液恶性肿瘤(HMs)。对病理和血液学诊断进行了复查,根据国际肿瘤疾病分类第 3 版(ICD-O-3)进行了重新编码,并根据 ICCC-3 进行了重新分类。采用世界人口作为标准,计算了性别和年龄调整后的发病率。在研究期间,赫罗纳、瓦伦西亚和萨拉戈萨癌症登记处共登记了 571 例 HMs。根据 ICCC-3,前体细胞白血病是儿童中最常见的 HMs,占所有 HMs 的 60%(年龄调整后发病率为每百万儿童年 42.7 例)。第二常见的儿童 HM 是霍奇金淋巴瘤(占所有 HMs 的 11.2%),年龄调整后标准化发病率为每百万儿童年 6.3 例。就髓系而言,急性髓细胞白血病最常见,发病率为每百万儿童年 7.9 例。淋巴细胞白血病(1.19)和伯基特淋巴瘤(3.94)的标准化发病率明显高于欧洲观察到的发病率。与欧洲数据相比,西班牙的淋巴细胞白血病和淋巴瘤发病率较高。特别是伯基特淋巴瘤的发病率较高。这种地理差异的原因尚不清楚。